Oxford Nanopore Technologies Plc (Oxford Nanopore) specializes in the development of DNA/RNA sequencing technology. The company develops sequencing devices that offer real-time analysis and scalable formats for various applications. The company’s products include Flongle, MinION, PromethION and GridION used for the analysis of DNA, RNA, proteins, small molecules and other types of molecules. Its products find applications in various areas of research such as microbiology, basic genome research, human genetics, cancer research, environmental research, microbiome, clinical research, population genomics, plant research, transcriptome analysis and animal research. The company also offers support, certification and training services. The company has business operations into the Uk, the US, China and Japan. Oxford Nanopore is headquartered in Oxford, Greater London, the UK.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Report Scope
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Oxford Nanopore Technologies Plc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
- Oxford Nanopore Technologies Plc Company Overview
- Oxford Nanopore Technologies Plc Company Snapshot
- Oxford Nanopore Technologies Plc Pipeline Products and Ongoing Clinical Trials Overview
- Oxford Nanopore Technologies Plc - Pipeline Analysis Overview
- Business Description
- Oxford Nanopore Technologies Plc - Key Facts
- Oxford Nanopore Technologies Plc - Major Products and Services
- Oxford Nanopore Technologies Plc Pipeline Products by Development Stage
- Oxford Nanopore Technologies Plc Ongoing Clinical Trials by Trial Status
- Oxford Nanopore Technologies Plc Pipeline Products Overview
- AmPORE-TB
- AmPORE-TB Product Overview
- LamPORE COVID-19 Test Kit
- LamPORE COVID-19 Test Kit Product Overview
- LamPORE Respiratory Panel
- LamPORE Respiratory Panel Product Overview
- Nanopore Sequencing Software
- Nanopore Sequencing Software Product Overview
- Nanopore Sequencing Software Clinical Trial
- Portable DNA Sequencing Tool
- Portable DNA Sequencing Tool Product Overview
- ROBIN
- ROBIN Product Overview
- SmidgION
- SmidgION Product Overview
- TraxION
- TraxION Product Overview
- Oxford Nanopore Technologies Plc - Key Competitors
- Oxford Nanopore Technologies Plc - Key Employees
- Oxford Nanopore Technologies Plc - Key Employee Biographies
- Oxford Nanopore Technologies Plc - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- Oxford Nanopore Technologies Plc, Recent Developments
- May 21, 2026: Oxford Nanopore Technologies Announces London Calling Technology Update
- Apr 15, 2026: Cepheid and Oxford Nanopore Expand Partnership After Successful Phase One Collaboration
- Feb 27, 2026: Oxford Nanopore Technologies Update on legal action against MGI Australia Pty Ltd., in the Federal Court of Australia
- Jan 28, 2026: ABL Diagnostics Strengthens Supplier Agreements to Support Growth
- Jan 07, 2026: Oxford Nanopore Technologies Announces Upcoming Investor Events and Conferences
- Dec 08, 2025: Oxford Nanopore Technologies Announces Appointment of Francis Van Parys as Chief Executive Officer
- Nov 05, 2025: Oxford Nanopore And BioMérieux Launch AmPORE-TB For Rapid Characterisation Of Drug Resistant Tuberculosis
- Nov 05, 2025: Oxford Nanopore and bioMérieux launch AmPORE-TB, a Research Use Only sequencing-based solution to rapidly characterize drug resistant-tuberculosis
- Oct 15, 2025: Oxford Nanopore Announces PromethION Plus Flow Cell and Human Genetics Updates at ASHG 2025
- Oct 09, 2025: Bio-Techne and Oxford Nanopore Technologies Strengthen Partnership for Genetic Product Development
- Appendix
- Methodology
- About the Analyst
- Contact the Publisher
- Disclaimer
- Oxford Nanopore Technologies Plc Pipeline Products and Ongoing Clinical Trials Overview
- Oxford Nanopore Technologies Plc Pipeline Products by Equipment Type
- Oxford Nanopore Technologies Plc Pipeline Products by Indication
- Oxford Nanopore Technologies Plc Ongoing Clinical Trials by Trial Status
- Oxford Nanopore Technologies Plc, Key Facts
- Oxford Nanopore Technologies Plc, Major Products and Services
- Oxford Nanopore Technologies Plc Number of Pipeline Products by Development Stage
- Oxford Nanopore Technologies Plc Pipeline Products Summary by Development Stage
- Oxford Nanopore Technologies Plc Ongoing Clinical Trials by Trial Status
- Oxford Nanopore Technologies Plc Ongoing Clinical Trials Summary
- AmPORE-TB - Product Status
- AmPORE-TB - Product Description
- LamPORE COVID-19 Test Kit - Product Status
- LamPORE COVID-19 Test Kit - Product Description
- LamPORE Respiratory Panel - Product Status
- LamPORE Respiratory Panel - Product Description
- Nanopore Sequencing Software - Product Status
- Nanopore Sequencing Software - Product Description
- Nanopore Sequencing Software - Application of Oxford Nanopore Adaptive Sequencing Method in Infection Post Liver Transplantation
- Nanopore Sequencing Software - Contribution of Metagenomic Sequencing Using Nanopore Technology to the Management of Post-traumatic Bone and Joint Infections
- Portable DNA Sequencing Tool - Product Status
- Portable DNA Sequencing Tool - Product Description
- ROBIN - Product Status
- ROBIN - Product Description
- SmidgION - Product Status
- SmidgION - Product Description
- TraxION - Product Status
- TraxION - Product Description
- Oxford Nanopore Technologies Plc, Key Employees
- Oxford Nanopore Technologies Plc, Key Employee Biographies
- Oxford Nanopore Technologies Plc, Other Locations
- Oxford Nanopore Technologies Plc, Subsidiaries
- Glossary
- Oxford Nanopore Technologies Plc Pipeline Products by Equipment Type
- Oxford Nanopore Technologies Plc Pipeline Products by Development Stage
- Oxford Nanopore Technologies Plc Ongoing Clinical Trials by Trial Status
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Source BioScience (Healthcare) Ltd
- Roche Diagnostics International Ltd
- Quest Diagnostics Inc
- Pacific Biosciences of California Inc
- Illumina Inc
- Exact Sciences Corp
- Adaptive Biotechnologies Corp
